$0.4950
At close: Mar 26, 4:00 PM EST
LYRA THERAPEUTICS INC by Lyra Therapeutics, Inc.
LYRAOTCEM
LYRA THERAPEUTICS INC by Lyra Therapeutics fell 95.1% from $3.85 to $0.19, behind the S&P 500's +12.3%. Its worst day was Aug 19 (−98.9%), and its low came Aug 19 at $0.00.
Nov 14, 2025 – Nov 12, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
LYRA THERAPEUTICS INC by Lyra Therapeutics closed at its highest level of the year, 16.9% above where the year started.
+7.4% · S&P 500 +0.1%
EPS of $-3.77 beat the $-4.78 estimate on $7,000.00 revenue (est. $187,000.00).
Story events cover the past 12 months · Times ET
−0.2% · S&P 500 +0.8%
LYRA THERAPEUTICS INC by Lyra Therapeutics closed at its lowest level of the year, 100.0% below where the year started.
−98.9%, the year's worst day · S&P 500 +0.2%
LYRA THERAPEUTICS INC by Lyra Therapeutics shares rose 1900.0%, while the S&P 500 fell 0.2%.
+1900.0% · S&P 500 −0.2%
Where it ended: a close of $0.19 on Nov 12, 2026.
Nothing in the past 12 months.
All LYRA analyst actionsNothing in the past 12 months.
All LYRA dividend history
